| | | | | | | |
 | JOHNSON & JOHNSON | 0.74% | 0.27% | 4.14% | 4.56% | 28.91% | 465 363 |
 | PFIZER, INC. | 1.43% | 1.79% | -14.25% | 26.24% | 21.60% | 280 096 |
 | ABBVIE INC. | 1.56% | 0.44% | 15.14% | 33.37% | 96.10% | 271 251 |
 | ELI LILLY AND COMPANY | 3.51% | -1.78% | 9.29% | 54.39% | 158.61% | 262 514 |
 | ROCHE HOLDING AG | 1.07% | -8.28% | -14.96% | 5.81% | 21.66% | 258 421 |
 | NOVO NORDISK A/S | -1.88% | -5.86% | 0.00% | 48.95% | 134.60% | 238 221 |
 | MERCK & CO., INC. | 1.57% | 2.29% | 19.82% | 14.97% | 16.05% | 228 629 |
 | ASTRAZENECA PLC | 1.13% | -0.35% | 19.87% | 31.75% | 76.90% | 195 003 |
 | NOVARTIS AG | 1.35% | 2.00% | 9.03% | 9.21% | 4.40% | 190 936 |
 | BRISTOL-MYERS SQUIBB COMPANY | 1.33% | -1.13% | 23.19% | 17.34% | 63.01% | 161 383 |
 | AMGEN INC. | 1.03% | 2.92% | 8.44% | -3.34% | 43.57% | 130 024 |
 | SANOFI | 0.21% | 2.82% | 12.89% | 14.10% | 33.26% | 129 701 |
 | GLAXOSMITHKLINE PLC | 1.94% | -0.77% | 11.38% | 29.70% | 15.45% | 108 703 |
 | BAYER AG | 2.71% | 2.81% | 34.49% | 11.34% | 10.33% | 62 932 |
 | CHUGAI PHARMACEUTICAL CO., LTD | -0.70% | -6.58% | -4.52% | -13.45% | 53.27% | 45 697 |
| | | | | | | |
| Moyenne | 1.13% | -0.63% | 8.93% | 19.00% | 51.85% | |
| Moyenne pondérée par Capi. | 1.15% | -0.68% | 6.75% | 21.41% | 55.89% | |